Brad has more than 25 years’ experience in the medical education and pharmaceutical industries. He founded QDcme, and he previously co-founded QD Holdings and its subsidiaries, QD Healthcare Group and Continuing Education Alliance (CEA), in 2000.

Brad co-managed QD Healthcare Group until its sale in 2012. He then served as CEO of CEA and was responsible for conceiving and launching the Practicing Clinicians Exchange (PCE), a continuing education live and online platform exclusively for NPs and PAs. As CEO and Chairman of PCE/CEA Holdings, Brad was responsible for the acquisition of Clinical Care Options (CCO) in early 2019 when he also was a member of the Board of Directors.

Prior to QD Holdings, Brad was Executive Vice President of Doctors Net Access, where he joined the company’s management team to build and grow the company. Prior to DNA, Brad was a principal of Clinical Communications Group. He joined the company as a startup and helped grow the business to over 170 employees in less than 6 years.  Brad began his career in the pharmaceutical industry working for Syntex and Berlex Laboratories